Real-world effectiveness and safety of vedolizumab induction therapy for Crohn's disease in Poland - a prospective, observational POLONEZ II study considering patients reported outcomes.

被引:0
|
作者
Liebert, A. [1 ]
Klopocka, M. [1 ]
Cichoz-Lach, H. [2 ]
Michalak, A. [2 ]
Talar-Wojnarowska, R. [3 ]
Domzal-Magrowska, D. [3 ]
Filipiuk, A. [4 ]
Krogulecki, M. [4 ]
Kopertowska-Majchrzak, M. [5 ]
Eder, P. [6 ]
Stawczyk-Eder, K. [6 ]
Waszak, K. [6 ]
Zagorowicz, E. [7 ,8 ]
Wojciechowski, K. [9 ,10 ]
Drygala, S. [9 ]
机构
[1] Nicolaus Copernicus Univ, Coll Medicum Bydgoszcz, Dept Gastroenterol & Nutr Disorders, Bydgoszcz, Poland
[2] Med Univ Lublin, Dept Gastroenterol, Lublin, Poland
[3] Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland
[4] Mil Inst Med, Dept Gastroenterol, Warsaw, Poland
[5] Gen Hosp, Dept Internal Dis, Miedzychod, Poland
[6] Poznan Univ Med Sci, H Swiecicki Univ Hosp, Dept Gastroenterol Dietet & Internal Dis, Poznan, Poland
[7] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Gastroenterol, Warsaw, Poland
[8] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland
[9] Takeda Pharma Sp Zoo, Med Affairs, Warsaw, Poland
[10] Dept Internal Dis, Independent Publ Hlth Care Ctr, Tarczyn, Poland
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P421
引用
收藏
页码:550 / 551
页数:2
相关论文
共 50 条
  • [1] Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II)
    Liebert, Ariel
    Klopocka, Maria
    Michalak, Agata
    Cichoz-Lach, Halina
    Talar-Wojnarowska, Renata
    Domzal-Magrowska, Danuta
    Konecki, Lukasz
    Filipiuk, Aleksandra
    Krogulecki, Michal
    Kopertowska-Majchrzak, Maria
    Stawczyk-Eder, Kamila
    Waszak, Katarzyna
    Eder, Piotr
    Zagorowicz, Edyta
    Smola, Izabela
    Wojciechowski, Krzysztof
    Drygala, Szymon
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [2] Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study
    Zagorowicz, Edyta
    Cichoz-Lach, Halina
    Kopertowska-Majchrzak, Maria
    Eder, Piotr
    Stawczyk-Eder, Kamila
    Talar-Wojnarowska, Renata
    Zatorski, Hubert
    Solarska-Polchlopek, Anna
    Filip, Rafal
    Janiak, Maria
    Skrobot, Krzysztof
    Klopocka, Maria
    Liebert, Ariel
    Kaczka, Aleksandra
    Wojciechowski, Krzysztof
    Drygala, Szymon
    Michalak, Agata
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (01): : 69 - 77
  • [3] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease
    Rajat Garg
    Manik Aggarwal
    Abdul Mohammed
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Indian Journal of Gastroenterology, 2023, 42 : 718 - 723
  • [4] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn's disease
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (05) : 718 - 723
  • [5] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean-Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin L.
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S560
  • [6] Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn's disease: a KASID prospective multicenter study
    Oh, Kyunghwan
    Hong, Hee Seung
    Ham, Nam Seok
    Lee, Jungbok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Yoon, Hyuk
    Kim, You Sun
    Choi, Chang Hwan
    Ye, Byong Duk
    INTESTINAL RESEARCH, 2022, : 137 - 147
  • [7] Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center
    Zinger, Adar
    Choi, David K.
    Choi, Natalie K.
    Garcia, Nicole M.
    Cohen, Russell D.
    Dalal, Sushila
    Cleveland, Noa Krugliak
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S834 - S834
  • [8] Effectiveness and Safety of ustekinumab in the Treatment of Penetrating Crohn's Disease: A Prospective Real-World Study
    Wu, Y.
    Huang, Z.
    Deng, X.
    Chao, K.
    Wu, Yan-Hui
    Huang, Zhao-Peng
    Deng, Xiao-Xia
    Lin, Min-Zhi
    Huang, Zi-Cheng
    Gao, Xiang
    Chao, Kang
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1413 - i1414
  • [9] Effectiveness and Safety of Upadacitinib Induction Therapy in Real-World Setting for 234 Patients with Crohn's Disease: A GETAID Multicentre Cohort Study
    Richard, N.
    Amiot, A.
    Seksik, P.
    Altwegg, R.
    Laharie, D.
    Vuitton, L.
    Nachury, M.
    Nancey, S.
    Bouguen, G.
    Gilletta, C.
    Rouillon, C.
    Coffin, B.
    Allez, M.
    Buisson, A.
    Le Berre, C.
    Pelletier, A. L.
    Uzzan, M.
    Caillo, L.
    Sickersen, G.
    Hupe, M.
    Abitbol, V
    Vidon, M.
    Goutorbe, F.
    Amil, M.
    Brixi, H.
    Benezech, A.
    Kwiatek, S.
    Peyrin-Biroulet, L.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1948 - i1950
  • [10] Systematic Literature Review of Real-World Effectiveness and Safety of Vedolizumab in Adult Ulcerative Colitis and Crohn's Disease Patients
    Demuth, Dirk
    Bovens, Sandra
    Solaman, Angela
    Curtis, Rebecca
    O'Byrne, Sharon
    Khalid, Javaria Mona
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S298 - S298